Desarrollo de Vacunas
National Cancer Institute
Rockville, Estados UnidosPublicaciones en colaboración con investigadores/as de National Cancer Institute (4)
2021
-
Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy
Cancer Letters, Vol. 499, pp. 279-289
2006
-
Epitope enhancement of a CD4 HIV epitope toward the development of the next generation HIV vaccine
Journal of Immunology, Vol. 176, Núm. 6, pp. 3753-3759
2000
-
Expression of proadrenomedullin derived peptides in the mammalian pituitary: Co-localization of follicle stimulating hormone and proadrenomedullin N-20 terminal peptide-like peptide in the same secretory granules of the gonadotropes
Journal of Neuroendocrinology, Vol. 12, Núm. 7, pp. 607-617
1998
-
Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions
Journal of Clinical Investigation, Vol. 102, Núm. 6, pp. 1239-1248